| Dr Patrick Joseph Rizzuto Iii, MD | |
|
89 French Street, Chinj 1360, New Brunswick, NJ 08901 | |
| (732) 235-9378 | |
| (732) 235-5002 |
| Full Name | Dr Patrick Joseph Rizzuto Iii |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 89 French Street, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063867836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 25MA11534700 (New Jersey) | Secondary |
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 25MA11534700 (New Jersey) | Primary |
| Entity Name | Rutgers Health-rwj Scleroderma Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
"Comparative Effectiveness will have the most significant impact on the orthopaedic industry moving forward," noted John Engelhardt in his luncheon Keynote Address today at the 6th Annual Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) in Chicago, Illinois. Mr. Engelhardt, CEO of ORTHOWORLD Inc. and Managing Member of Knowledge Ventures, LLC, emphasized that industry will be compelled to adopt the concept of comparative effectiveness throughout its business models in order to gain the efficiencies required to thrive in the future.
No matter the trigger - bug bites, a medication side-effect or an itchy wound - the urge to scratch can be a real pain. Researchers at the Duke University Medical Center have identified a potential drug target in the skin for that itchy feeling.
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received approval for three antiretroviral (ARV) therapies used to treat HIV/AIDS under the World Health Organization's (WHO) Prequalification of Medicines Programme. The products include:
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Joseph Rizzuto Iii, MD 89 French Street, Suite 2300, New Brunswick, NJ 08901 Ph: (732) 235-9378 | Dr Patrick Joseph Rizzuto Iii, MD 89 French Street, Chinj 1360, New Brunswick, NJ 08901 Ph: (732) 235-9378 |
News Archive
"Comparative Effectiveness will have the most significant impact on the orthopaedic industry moving forward," noted John Engelhardt in his luncheon Keynote Address today at the 6th Annual Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) in Chicago, Illinois. Mr. Engelhardt, CEO of ORTHOWORLD Inc. and Managing Member of Knowledge Ventures, LLC, emphasized that industry will be compelled to adopt the concept of comparative effectiveness throughout its business models in order to gain the efficiencies required to thrive in the future.
No matter the trigger - bug bites, a medication side-effect or an itchy wound - the urge to scratch can be a real pain. Researchers at the Duke University Medical Center have identified a potential drug target in the skin for that itchy feeling.
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received approval for three antiretroviral (ARV) therapies used to treat HIV/AIDS under the World Health Organization's (WHO) Prequalification of Medicines Programme. The products include:
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
› Verified 7 days ago
Dr. I. Mark Hiatt, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 Fax: 732-249-9572 | |
Lynne Weiss, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 89 French Street, Suite 2300, New Brunswick, NJ 08901 Phone: 732-235-6230 Fax: 732-235-6620 | |
Margaret Masterson, Pediatrics Medicare: Medicare Enrolled Practice Location: 195 Little Albany St, New Brunswick, NJ 08901 Phone: 732-235-6455 Fax: 732-235-6462 | |
Lisanne Hauck, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Robert Wood Johnson Pl, Robert Wood Johnson University Hospital - New Brunswick, New Brunswick, NJ 08901 Phone: 732-235-7900 | |
Daniel Notterman, Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, Robert Wood Johnson University Hospital - New Brunswick, New Brunswick, NJ 08901 Phone: 732-235-7900 | |
Minh-tu Do, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, Meb 342, New Brunswick, NJ 08901 Phone: 732-235-7893 Fax: 732-235-9340 | |
Christoph Ohngemach, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 Fax: 732-745-8725 |